1 February 2022, Auckland, NZ, — Global Medical Solutions (NZ) Ltd. (GMS) and Integral Diagnostics New Zealand (IDX), (a subsidiary of Integral Diagnostics Ltd, listed on Australia Stock Exchange (ASX:IDX)), have completed a transaction whereby GMS will divest its Auckland Branch of it’s New Zealand Medical Imaging (NZMI) operations to IDX and the parties have entered into a long-term supply agreement for nuclear medicine consumables. GMS will continue to operate its NZMI Hamilton branch.

NZMI’s presence in the Auckland market grew out of a need for private cameras. At the time we saw the per capita SPECT service availability did not meet the global standards and we committed ourselves to invest and deliver much-needed services to the Auckland patient base.

Over the last couple of years, we’ve seen an emergence of dedication to SPECT scanning services from companies like SRG Radiology. SRG Radiology have been long-term customers to GMS’s radiopharmaceutical business, and we are excited to see their continued growth in our markets. This transaction better aligns our supplier-customer relationships and allows us to focus on our core business of radiopharmaceutical supplies. We look forward to taking the next steps in bringing a GMP quality SPECT and PET Cyclotron Unit Dose Pharmacy to the Auckland marketplace.